Veritable, L.P. Organon & Co. Transaction History

Veritable, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $177,831 - $218,265	7,629 New	7,629 $213,000
Q2 2022 Aug 15, 2022	BUY	$31.66 - $38.9 $6,047 - $7,429	191 Added 2.05%	9,508 $321,000
Q1 2022 May 11, 2022	SELL	$30.45 - $39.36 $5,176 - $6,691	-170 Reduced 1.79%	9,317 $325,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $23,194 - $30,038	-809 Reduced 7.86%	9,487 $289,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $93,333 - $116,186	-3,260 Reduced 24.05%	10,296 $338,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $385,668 - $515,128	13,556 New	13,556 $410,000

809

207M

1.19M

910K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.